ELIAS JOSEPH JABBOUR to Stomatitis
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Stomatitis.
Connection Strength
0.058
-
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia. Am J Hematol. 2016 08; 91(8):800-5.
Score: 0.032
-
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia. Cancer. 2013 Jul 15; 119(14):2611-9.
Score: 0.026